Evidence map›Paper›PMID 18982324›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2009

Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.

Wengen Chen, Gonca G Bural, Drew A Torigian, Daniel J Rader, Abass Alavi

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Review
  7. Review
  8. Experimental and therapeutic medicine · 2021
    Article
  9. Diagnostic Role and Feasibility ofAnnals of nuclear cardiology · 2020
    Review
  10. Detection of pulmonary artery atherosclerosis by FDG-PET/CT: a new observation.American journal of nuclear medicine and molecular imaging · 2020
    Article
  11. Article
  12. Review
  13. Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018 · on this map
    Article
  14. Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  15. Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. PET/MRI: current state of the art and future potential for cardiovascular applications.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Review
  20. Radiotracer imaging of peripheral vascular disease.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wengen ChenDivision of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 110 Donner Building, 3400 Spruce St., Philadelphia, PA 19104, USA.
Gonca G Bural
Drew A Torigian
Daniel J Rader
Abass Alavi
Hospital of the University of Pennsylvania · USTranslational Therapeutics (United States) · US

Funding

NCI NIH HHS 1-T32 CA093258A85-01A1
6 · The paper itself

Abstract

Atherosclerosis is a dynamic inflammatory disorder. The biological composition and inflammatory state of an atherosclerotic plaque, rather than the degree of stenosis or its size are the major determinants of acute clinical events. A noninvasive technique to detect vulnerable atherosclerotic plaque is critically needed. FDG-PET/CT, a combined functional and structural whole-body imaging modality, holds great potential for this purpose. FDG uptake in large arteries has been frequently observed and is associated with cardiovascular risk factors. FDG accumulates in plaque macrophages and uptake is correlated with macrophage density. It is known that vascular FDG uptake and calcification do not overlap significantly and changes of FDG uptake are common, suggesting that FDG uptake may represent a dynamic inflammatory process. It has been reported that vascular FDG uptake can be attenuated by simvastatin in patients, and by the antiinflammatory drug probucol in rabbits. Vascular FDG uptake has been linked to cardiovascular events in some preliminary studies. Data from basic sciences, and animal and clinical studies support the emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries in humans.

Indexed as

Fluorodeoxyglucose F18AngiographyAnimalsArteriesAtherosclerosisHumansPositron-Emission TomographyTomography, X-Ray ComputedFluorodeoxyglucose F18

Identifiers

PMID18982324
OpenAlexW2090434824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.